These data indicated that blocking IL-8/STAT3 signaling of TAMs can evidently hinder the communication between the tumor and the host stromal cells, suggesting it as a novel therapeutic target for cancer stem cells that mediate the evolution of ovarian cancer and other malignant diseases. Here, CXCL8 is linked to neoplasm.